New PET scan imaging test for solid tumors
Part of Cancer clinical trials.
This trial tests a new type of PET scan (a special imaging test) called 89Zr-s-C1 to help detect and monitor solid tumors like melanoma, gastric cancer, or colorectal cancer. The scan may help doctors see tumors more clearly and track whether treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Pathologically confirmed (biopsy-proven) solid tumor that is newly diagnosed, recently recurred, or suspected to have recurred
- Blood counts and liver/kidney function tests within acceptable ranges
- Expected to live at least 12 weeks
- At least one measurable tumor visible on imaging (RECIST criteria)
- Able to lie flat for 30 minutes without moving
- Willing and able to follow study instructions and sign consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This trial is testing a new imaging agent called RT01-89Zr to see if it can help detect solid tumors during PET/CT scans. It involves an injection of the agent followed by imaging, and may offer a more targeted way to visualize tumors.
This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
This study uses a new imaging tracer, called 68Ga-SorB, during a PET/CT scan to look at tumors. It may help doctors see cancer more clearly. The trial is for adults with certain types of solid tumors (such as melanoma, liver, lung, breast, pancreatic, ovarian, or bile duct cancer) who need a PET/CT scan as part of their care.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.